WHO clears Pfizer-BioNTech coronavirus vaccine for emergency use
The World Health Organization says it has
cleared the Pfizer-BioNTech coronavirus vaccine for emergency use,
meaning poorer countries may soon get access to the shot already available in
Europe and North America.
Every country that has a drug regulatory agency will have to issue its own approval for any COVID-19 vaccine, but countries with weak systems usually rely on WHO to vet the shots.
The
global body said late Thursday that the decision to issue its first emergency
use validation for a COVID-19 vaccine "opens the door for countries to
expedite their own regulatory approval processes to import and administer the
vaccine."
The UN
health agency said its review found the Pfizer-BioNTech vaccine, which has
already received clearance in the United States, Britain, the European Union
and a dozen other countries, "met the must-have criteria for safety and
efficacy set out by WHO." Read More
Comments
Post a Comment